Unknown

Dataset Information

0

Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.

ABSTRACT: Given its catalytic activity to generate diacylglycerol and inositol 1,4,5-trisphosphate, phospholipase C (PLC) is implicated in promoting cell growth. However, we found that PLC-beta3-deficient mice develop myeloproliferative disease, lymphoma, and other tumors. The mutant mice have increased numbers of hematopoietic stem cells with increased proliferative, survival, and myeloid-differentiative abilities. These properties are dependent on Stat5 and can be antagonized by the protein phosphatase SHP-1. Stat5-dependent cooperative transformation by active c-Myc and PLC-beta3 deficiency was suggested in mouse lymphomas in PLC-beta3(-/-) and in Emicro-myc;PLC-beta3(+/-) mice and human Burkitt's lymphoma cells. The same mechanism for malignant transformation seems to be operative in other human lymphoid and myeloid malignancies. Thus, PLC-beta3 is likely a tumor suppressor.

SUBMITTER: Xiao W 

PROVIDER: S-EPMC2744338 | biostudies-other | 2009 Aug

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Given its catalytic activity to generate diacylglycerol and inositol 1,4,5-trisphosphate, phospholipase C (PLC) is implicated in promoting cell growth. However, we found that PLC-beta3-deficient mice develop myeloproliferative disease, lymphoma, and other tumors. The mutant mice have increased numbers of hematopoietic stem cells with increased proliferative, survival, and myeloid-differentiative abilities. These properties are dependent on Stat5 and can be antagonized by the protein phosphatase  ...[more]

Similar Datasets

Unknown Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.
| S-EPMC3031387 | biostudies-literature
Unknown Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK/STAT3 pathway by tubocapsenolide A.
| S-EPMC8655134 | biostudies-literature
Unknown Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.
| S-EPMC6883818 | biostudies-literature
Unknown Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.
| S-EPMC3124618 | biostudies-literature
Unknown Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation.
| S-EPMC3306555 | biostudies-literature
Unknown NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation.
| S-EPMC416407 | biostudies-literature
Unknown 2-Aminoethoxydiphenylborane sensitizes anti-tumor effect of bortezomib via suppression of calcium-mediated autophagy.
| S-EPMC5834458 | biostudies-literature
Unknown Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.
| S-EPMC5983346 | biostudies-literature
Unknown Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.
| S-EPMC7507000 | biostudies-literature
Unknown Phospholipase C beta3 is a key component in the Gbetagamma/PKCeta/PKD-mediated regulation of trans-Golgi network to plasma membrane transport.
| S-EPMC1948997 | biostudies-literature